Reduced-Dose Thrombolysis in Acute Pulmonary Embolism A Systematic Review
Angiology · 2024-03 · 75 (3) · 208-218
DOI: 10.1177/00033197231167062 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Angiology, online erschienen am 15.04.2023. Verfasst von Adrian Rojas Murguia und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Texas Tech University Health Sciences Center of El Paso, Texas, TX, USA. Hauptthemen laut MEDLINE: Thrombolytic Therapy, Pulmonary Embolism. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 63 Literaturangaben.
Abstract (Originalsprache)
Pulmonary embolism (PE) is the third-leading cause of cardiovascular mortality and the second-leading cause of death in cancer patients. The clinical efficacy of thrombolysis for acute PE has been proven, yet the therapeutic window seems narrow, and the optimal dosing for pharmaceutical reperfusion therapy has not been established. Higher doses of systemic thrombolysis inevitably associated with an incremental increase in major bleeding risk. To date, there is no high-quality evidence regarding dosing and infusion rates of thrombolytic agents to treat acute PE. Most clinical trials have focused on thrombolysis compared with anticoagulation alone, but dose-finding studies are lacking. Evidence is now emerging that lower-dose thrombolytic administered through a peripheral vein is efficacious in accelerating thrombolysis in the central pulmonary artery and preventing acute right heart failure, with reduced risk for major bleeding. The present review will systematically summarize the current evidence of low-dose thrombolysis in acute PE.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Texas Tech University Health Sciences Center of El Paso, Texas, TX, USA.
- Division of Cardiovascular Medicine, Department of Internal Medicine, Health Sciences Center of El Paso, Texas, TX, USA.
- Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Texas Tech University Health Sciences Center of El Paso, Texas, TX, USA.
ORCID-Profile: Adrian Rojas Murguia, Debabrata Mukherjee
Zitieren
APA
Murguia, A. R., Mukherjee, D., Ojha, C., Rajachandran, M., Siddiqui, T. S., & Nickel, N. P. (2024). Reduced-Dose Thrombolysis in Acute Pulmonary Embolism A Systematic Review. Angiology, 75(3), 208-218. https://doi.org/10.1177/00033197231167062
Vancouver
Murguia AR, Mukherjee D, Ojha C, Rajachandran M, Siddiqui TS, Nickel NP. Reduced-Dose Thrombolysis in Acute Pulmonary Embolism A Systematic Review. Angiology. 2024;75(3):208-218. doi:10.1177/00033197231167062
BibTeX
@article{Murguia2024,
author = {Murguia, Adrian Rojas and Mukherjee, Debabrata and Ojha, Chandra and Rajachandran, Manu and Siddiqui, Tariq S and Nickel, Nils P},
title = {Reduced-Dose Thrombolysis in Acute Pulmonary Embolism A Systematic Review},
journal = {Angiology},
year = {2024},
volume = {75},
number = {3},
pages = {208--218},
doi = {10.1177/00033197231167062}
}
EUVIMED